CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Net sales	$ 157,927	$ 138,187	$ 457,006	$ 407,700
Cost of goods sold	99,117	84,367	283,670	247,586
Gross profit	58,810	53,820	173,336	160,114
Selling expenses	44,736	40,377	132,979	117,912
General and administrative expenses	13,766	9,196	39,007	31,925
Restructuring and other transition expenses	52	2,547	311	9,542
Net gain from sale of Torrance Facility	0	0	0	(37,449)
Net gains from sale of spice assets	(110)	(272)	(655)	(764)
Net gains from sales of other assets	(590)	(86)	(446)	(1,525)
Impairment losses on intangible assets	3,820	0	3,820	0
Operating expenses	61,674	51,762	175,016	119,641
(Loss) income from operations	(2,864)	2,058	(1,680)	40,473
Other (expense) income:
Dividend income	1	273	12	808
Interest income	0	147	2	435
Interest expense	(902)	(517)	(2,286)	(1,430)
Other, net	154	1,044	794	(1,088)
Total other (expense) income	(747)	947	(1,478)	(1,275)
(Loss) income before taxes	(3,611)	3,005	(3,158)	39,198
Income tax expense	297	1,411	20,497	15,910
Net (loss) income	(3,908)	1,594	(23,655)	23,288
Less: Cumulative preferred dividends, undeclared and unpaid	128	0	257	0
Net (loss) income available to common stockholders	$ (4,036)	$ 1,594	$ (23,912)	$ 23,288
Net income (loss) per common share - basic (in US$ per share)	$ (0.24)	$ 0.10	$ (1.43)	$ 1.40
Net income (loss) per common share - diluted (in US$ per share)	$ (0.24)	$ 0.10	$ (1.43)	$ 1.39
Weighted average common shares outstanding - basic (in shares)	16,760,145	16,605,754	16,727,624	16,584,125
Weighted average common shares outstanding—diluted (in shares)	16,760,145	16,721,774	16,727,624	16,704,200